HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meletios A Dimopoulos Selected Research

Carcinoma (Carcinomatosis)

1/2015Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.
1/2011A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.
1/2009Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication.
9/2008Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
3/2007Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.
1/2007Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment.
9/2006Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
8/2006Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
1/2006The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
6/2004Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meletios A Dimopoulos Research Topics

Disease

237Multiple Myeloma
12/2022 - 10/2003
74Neoplasms (Cancer)
11/2022 - 06/2003
43Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2022 - 05/2002
30Disease Progression
10/2022 - 07/2005
29Immunoglobulin Light-chain Amyloidosis
12/2021 - 06/2003
22Bone Diseases (Bone Disease)
03/2021 - 10/2006
20COVID-19
02/2022 - 01/2020
17Peripheral Nervous System Diseases (PNS Diseases)
10/2021 - 01/2004
17Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 12/2005
16Thrombocytopenia (Thrombopenia)
01/2022 - 04/2007
13Infections
01/2022 - 12/2008
12Neutropenia
01/2022 - 11/2010
12Amyloidosis
01/2022 - 02/2010
11Paraproteinemias (Monoclonal Gammopathy)
11/2022 - 04/2003
11Breast Neoplasms (Breast Cancer)
01/2021 - 04/2006
11Carcinoma (Carcinomatosis)
01/2015 - 06/2002
10Residual Neoplasm
01/2022 - 10/2016
10Prostatic Neoplasms (Prostate Cancer)
04/2016 - 01/2004
9Pain (Aches)
10/2021 - 02/2008
9Ovarian Epithelial Carcinoma
01/2020 - 05/2005
9Anemia
11/2018 - 12/2009
8Pneumonia (Pneumonitis)
01/2022 - 01/2016
7Monoclonal Gammopathy of Undetermined Significance
11/2022 - 04/2003
7Lymphoma (Lymphomas)
09/2021 - 04/2003
7Neoplasm Metastasis (Metastasis)
12/2020 - 09/2005
7Osteonecrosis (Kienbock's Disease)
10/2017 - 12/2005
6Plasmacytoma
06/2020 - 06/2002
6Bone Resorption
12/2019 - 03/2010
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2018 - 04/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 01/2002
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 12/2005
5Chromosome Aberrations (Chromosome Abnormalities)
01/2021 - 07/2012
5Venous Thromboembolism
01/2020 - 12/2008
5Hematologic Neoplasms (Hematological Malignancy)
04/2018 - 12/2005
5Renal Insufficiency (Renal Failure)
05/2016 - 08/2009
5Cytopenia
01/2016 - 01/2005
5Renal Cell Carcinoma (Grawitz Tumor)
02/2012 - 10/2004
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2022 - 06/2003
4Inflammation (Inflammations)
01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

105Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 01/2002
83Bortezomib (Velcade)FDA Link
01/2022 - 12/2005
70Lenalidomide (CC 5013)FDA Link
06/2022 - 03/2007
36Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 10/2003
33Proteasome InhibitorsIBA
06/2022 - 12/2005
32carfilzomibIBA
06/2022 - 01/2015
27Prednisone (Sone)FDA LinkGeneric
01/2022 - 08/2008
26daratumumabIBA
10/2022 - 10/2016
24pomalidomideIBA
01/2022 - 01/2013
24Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
21PlatinumIBA
11/2021 - 12/2004
20Immunoglobulin M (IgM)IBA
11/2022 - 04/2003
20Thalidomide (Thalomid)FDA Link
09/2019 - 10/2003
17Rituximab (Mabthera)FDA Link
01/2022 - 05/2002
17Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 06/2002
16Monoclonal AntibodiesIBA
12/2021 - 03/2009
15Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2005
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 06/2003
15Diphosphonates (Bisphosphonates)IBA
01/2020 - 12/2005
15Cisplatin (Platino)FDA LinkGeneric
01/2020 - 06/2002
11Pharmaceutical PreparationsIBA
04/2022 - 12/2007
11ixazomibIBA
01/2022 - 01/2019
11Immunomodulating AgentsIBA
01/2021 - 01/2005
10L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 03/2009
9BNT162 VaccineIBA
02/2022 - 01/2021
9Zoledronic Acid (Zometa)FDA Link
01/2021 - 12/2005
8Neutralizing AntibodiesIBA
05/2022 - 01/2021
8Carboplatin (JM8)FDA LinkGeneric
06/2016 - 01/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 01/2005
7VaccinesIBA
01/2022 - 01/2021
7CytokinesIBA
01/2022 - 06/2007
7Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2021 - 02/2010
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 01/2006
6elotuzumabIBA
06/2022 - 02/2017
6isatuximabIBA
05/2022 - 12/2019
6AntibodiesIBA
02/2022 - 06/2016
6selinexorIBA
01/2022 - 11/2020
6Amyloid (Amyloid Fibrils)IBA
01/2021 - 02/2010
6Pamidronate (Aredia)FDA LinkGeneric
10/2015 - 12/2005
5Messenger RNA (mRNA)IBA
01/2022 - 01/2013
5ibrutinibIBA
01/2022 - 06/2018
5DenosumabFDA Link
01/2021 - 05/2011
5PanobinostatIBA
01/2021 - 07/2013
5Immunoglobulins (Immunoglobulin)IBA
01/2021 - 06/2020
5Proteasome Endopeptidase Complex (Proteasome)IBA
12/2019 - 09/2010
5Angiopoietin-1IBA
10/2017 - 06/2007
5Angiopoietin-2IBA
10/2017 - 06/2007
5CreatinineIBA
04/2016 - 03/2009
5Docetaxel (Taxotere)FDA Link
10/2014 - 02/2008
5Alkaline PhosphataseIBA
01/2014 - 04/2011
5GemcitabineFDA Link
01/2010 - 07/2005
4Cell-Free Nucleic AcidsIBA
11/2022 - 12/2018
4mRNA VaccinesIBA
01/2022 - 01/2021

Therapy/Procedure

128Therapeutics
12/2022 - 12/2002
48Drug Therapy (Chemotherapy)
11/2021 - 01/2004
26Stem Cell Transplantation
06/2022 - 01/2003
13Radiotherapy
01/2021 - 01/2003
7Aftercare (After-Treatment)
01/2017 - 10/2003
7Adjuvant Chemotherapy
07/2015 - 04/2006
6Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 12/2005
4Transplantation
06/2022 - 05/2012